230 related articles for article (PubMed ID: 36705712)
1. Topical Review: Studies on Management of Myopia Progression from 2019 to 2021.
Lanca C; Repka MX; Grzybowski A
Optom Vis Sci; 2023 Jan; 100(1):23-30. PubMed ID: 36705712
[TBL] [Abstract][Full Text] [Related]
2. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
Huang J; Wen D; Wang Q; McAlinden C; Flitcroft I; Chen H; Saw SM; Chen H; Bao F; Zhao Y; Hu L; Li X; Gao R; Lu W; Du Y; Jinag Z; Yu A; Lian H; Jiang Q; Yu Y; Qu J
Ophthalmology; 2016 Apr; 123(4):697-708. PubMed ID: 26826749
[TBL] [Abstract][Full Text] [Related]
3. Optical interventions for myopia control.
Logan NS; Bullimore MA
Eye (Lond); 2024 Feb; 38(3):455-463. PubMed ID: 37740053
[TBL] [Abstract][Full Text] [Related]
4. Interventions to slow progression of myopia in children.
Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
[TBL] [Abstract][Full Text] [Related]
5. Recent updates on myopia control: preventing progression 1 diopter at a time.
Weiss RS; Park S
Curr Opin Ophthalmol; 2019 Jul; 30(4):215-219. PubMed ID: 31033732
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Gao C; Wan S; Zhang Y; Han J
Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia.
Zhou H; Zhao G; Li Y
Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial.
Yuan Y; Zhu C; Liu M; Zhou Y; Yang X; Zheng B; Li Z; Mao X; Ke B
Trials; 2021 Dec; 22(1):863. PubMed ID: 34852833
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
10. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
Gao Y; Yu Y
Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021.
Lanca C; Pang CP; Grzybowski A
Front Public Health; 2023; 11():1125000. PubMed ID: 37033047
[TBL] [Abstract][Full Text] [Related]
12. Overnight orthokeratology is comparable with atropine in controlling myopia.
Lin HJ; Wan L; Tsai FJ; Tsai YY; Chen LA; Tsai AL; Huang YC
BMC Ophthalmol; 2014 Mar; 14():40. PubMed ID: 24685184
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis.
Li SM; Kang MT; Wu SS; Liu LR; Li H; Chen Z; Wang N
Curr Eye Res; 2016 May; 41(5):600-8. PubMed ID: 26237276
[TBL] [Abstract][Full Text] [Related]
14. Myopia prevention and control in children: a systematic review and network meta-analysis.
Zhang G; Jiang J; Qu C
Eye (Lond); 2023 Nov; 37(16):3461-3469. PubMed ID: 37106147
[TBL] [Abstract][Full Text] [Related]
15. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
Yang N; Bai J; Liu L
Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effects of highly aspherical lenslets versus defocus incorporated multiple segment spectacle lenses on myopia control.
Guo H; Li X; Zhang X; Wang H; Li J
Sci Rep; 2023 Feb; 13(1):3048. PubMed ID: 36810369
[TBL] [Abstract][Full Text] [Related]
17. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
Yu Y; Liu J
Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467
[TBL] [Abstract][Full Text] [Related]
18. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis.
Tsai HR; Wang JH; Huang HK; Chen TL; Chen PW; Chiu CJ
J Formos Med Assoc; 2022 Dec; 121(12):2490-2500. PubMed ID: 35688780
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial.
Li Y; Fu Y; Wang K; Liu Z; Shi X; Zhao M
Trials; 2020 Mar; 21(1):279. PubMed ID: 32188478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
